These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4078730)

  • 1. Potentiation of pentazocine antinociception by tripelennamine in the rat.
    Yeh SY
    J Pharmacol Exp Ther; 1985 Dec; 235(3):683-9. PubMed ID: 4078730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):214-7. PubMed ID: 6707938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of pentazocine conditioned place preference by tripelennamine in rats.
    Suzuki T; Masukawa Y; Shiozaki Y; Misawa M
    Psychopharmacology (Berl); 1991; 105(1):9-12. PubMed ID: 1836064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical pharmacology of pentazocine and tripelennamine (T's and Blues).
    Lange WR; Jasinski DR
    Adv Alcohol Subst Abuse; 1986; 5(4):71-83. PubMed ID: 3751735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels.
    Shannon HE; Su TP
    Pharmacol Biochem Behav; 1982 Oct; 17(4):789-95. PubMed ID: 6294681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between pentazocine and tripelennamine on autonomic and nociceptive measures in the dog.
    Vaupel DB
    Pharmacol Biochem Behav; 1989 May; 33(1):245-51. PubMed ID: 2780781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of concomitant pentazocine and tripelennamine on brain-stimulation reward.
    Unterwald EM; Kornetsky C
    Pharmacol Biochem Behav; 1984 Dec; 21(6):961-4. PubMed ID: 6335254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pentazocine and tripelennamine on analgesia.
    Cleary J; Wallace S; Grossett D; Picker M; Poling A
    Pharmacol Biochem Behav; 1983 Dec; 19(16):911-5. PubMed ID: 6657717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine in the effects of pentazocine and tripelennamine.
    Hudzik TJ; Slifer BL
    Pharmacol Biochem Behav; 1990 Jul; 36(3):547-54. PubMed ID: 1974066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the synergistic lethality between pentazocine and vasopressin in the rat.
    Chau TT; Dewey WL; Harris LS
    J Pharmacol Exp Ther; 1973 Aug; 186(2):288-96. PubMed ID: 4719781
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of antihistaminic drugs on pentazocine antinociception in the rat.
    Yeh SY
    Pharmacol Biochem Behav; 1986 Apr; 24(4):925-30. PubMed ID: 2872685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripelennamine fails to enhance the morphine-like stimulus effects of pentazocine.
    Oliveto AH; Slifer BL; Dykstra LA
    Pharmacol Biochem Behav; 1988 Feb; 29(2):397-401. PubMed ID: 3362933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of lethality in mice by combinations of pentazocine and tripelennamine.
    Waller DP; Katz NL; Morris RW
    Clin Toxicol; 1980 Mar; 16(1):17-23. PubMed ID: 7389279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction of pentazocine and tripelennamine: drug discrimination and mu-receptor binding assay.
    Shook JE; Kallman MJ; Martin BR; Dewey WL
    Pharmacol Biochem Behav; 1984 Dec; 21(6):877-81. PubMed ID: 6097919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of pentazocine and tripelennamine.
    Yeh SY; Todd GD; Johnson RE; Gorodetzky CW; Lange WR
    Clin Pharmacol Ther; 1986 Jun; 39(6):669-76. PubMed ID: 3709032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice.
    Sansone M; Castellano C; Libri V
    Psychopharmacology (Berl); 1988; 95(2):176-9. PubMed ID: 3137594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripelennamine and pentazocine alone and in combination: effects on interresponse-time-greater-than-t responding of rats.
    Grossett D; Wallace S; Picker M; Poling A
    Pharmacol Biochem Behav; 1984 May; 20(5):697-700. PubMed ID: 6739513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.